Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

At a recent event in the Department of Pharmacology, featuring DPhil and MSC students along with early career researchers, the formation of the Oxford Pharmacology Society (OPS) was announced.

The society aims to provide a platform to invite speakers and alumni in the interest of networking and career advice. At an event in November, Dr Sridhar Vasudevan talked to the group about his journey from MSc student to Principal Investigator, including details of his involvement in an academic spinout. The next event, to be held on 16 January 2019, is entitled ‘Beyond academia: The intricate world of intellectual property’ and will be presented by Dr Tanya Heare-Rowlands, a former DPhil student in the Platt lab who is now an IP lawyer. The Society is being run by Dragos Mosneagu in the Vasudevan lab, Carla Santos and Mylene Huebecker in the Platt lab and Arup Nath in the Minichiello group. For full details see http://www.opharmsoc.co.uk – register here for the OPS mailing list. All graduate students and early career researchers welcome.

Similar stories

International collaboration by Potter group uncovers vital element in regulation of Na⁺/K⁺- ATPase-α1

Department

An international collaboration of the Potter Group with Solomon Snyder’s Group in the USA and with Chinese and German colleagues has uncovered the myo-inositol polyphosphate pyrophosphate 5-InsP7 as a regulator of the Na⁺/K⁺- ATPase-α1

Professor Angela Russell receives 2021 Harrington UK Rare Disease Scholar Award

Department Russell Group

Angela Russell, Professor of Medicinal Chemistry in the Oxford Departments of Pharmacology and Chemistry, has been announced as one of the five recipients of the inaugural UK Rare Disease Scholar Award, presented by the Harrington Discovery Institute (HDI).

Professor Fran Platt appointed as new Head of Department of Pharmacology

Department

Professor Fran Platt has been appointed as the new Head of Department for Pharmacology at the University of Oxford. Fran took up her new post with effect from 1 June 2020 and will serve for an initial period of five years.

The Department mourns the loss of three greats in neuropharmacology

Department

This summer three of the world’s most distinguished neurochemists died; each was a member of the Department during their outstanding scientific careers.

Professor Fran Platt secures £1M funding over two years for vital Parkinson's Disease research, in collaboration with Pfizer

Department

There is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson’s disease (PD).

New Galione group paper explores the role for early Ca2+ signals in phagocytosis

Department

The Galione Lab has a paper published in The EMBO Journal showing that local Ca2+‐nanodomains formed by two‐pore channels (TPCs) on endo-lysosomes are shown to drive phagocytosis in macrophages. Moreover, different endo-lysosomal Ca2+ channels do different jobs at phagocytosis (extreme compartmentation).